News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
GOODMAN COREY S
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| venBio Global Strategic Fund III, L.P. (10% Owner) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Granted 13,301 options to buy
@ $16.54, valued at
$220k
Granted 13,301 options to buy
@ $16.54, valued at
$220k
|
|
| 05/27/2022 |
4
| venBio Global Strategic Fund III, L.P. (10% Owner) has filed a Form 4 on Elevation Oncology, Inc.|
Txns:
| Sold 702,737 shares
@ $4.1236, valued at
$2.9M
|
|
| 05/17/2022 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Sold 35,850 shares
@ $10.4453, valued at
$374.5k
Sold 95,800 shares
@ $10.4499, valued at
$1M
|
|
| 05/12/2022 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Sold 18,676 shares
@ $10.3807, valued at
$193.9k
Sold 17,700 shares
@ $10.3752, valued at
$183.6k
Sold 124,525 shares
@ $10.394, valued at
$1.3M
|
|
| 05/09/2022 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Sold 20,743 shares
@ $10.37, valued at
$215.1k
Sold 48,334 shares
@ $10.3702, valued at
$501.2k
Sold 17,600 shares
@ $10.374, valued at
$182.6k
|
|
| 05/04/2022 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Sold 153,700 shares
@ $10.3837, valued at
$1.6M
Sold 79,475 shares
@ $10.3735, valued at
$824.4k
Sold 37,500 shares
@ $10.3713, valued at
$388.9k
|
|
| 04/29/2022 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Sold 47,396 shares
@ $10.3802, valued at
$492k
Sold 73,400 shares
@ $10.3806, valued at
$761.9k
Sold 69,230 shares
@ $10.3808, valued at
$718.7k
|
|
| 04/26/2022 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Sold 37,430 shares
@ $10.3883, valued at
$388.8k
Sold 27,668 shares
@ $10.3876, valued at
$287.4k
Sold 64,683 shares
@ $10.3823, valued at
$671.6k
|
|
| 04/21/2022 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Sold 399,923 shares
@ $10.4151, valued at
$4.2M
Sold 85,611 shares
@ $10.3887, valued at
$889.4k
Sold 62,200 shares
@ $10.3837, valued at
$645.9k
|
|
| 10/26/2021 |
4
| venBio Global Strategic Fund, L.P. (10% Owner) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Sold 75,035 shares
@ $1.6383, valued at
$122.9k
Sold 540,667 shares
@ $1.4907, valued at
$806k
|
|
| 10/25/2021 |
4
| venBio Global Strategic Fund III, L.P. (10% Owner) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Converted 3,684,769 shares
@ $0
Bought 312,500 shares
@ $16, valued at
$5M
Converted 3,289,742 preferred shares
@ $0
Converted 395,027 preferred shares
@ $0 |
|
| 10/20/2021 |
3
| venBio Global Strategic Fund III, L.P. (10% Owner) has filed a Form 3 on Ventyx Biosciences, Inc. |
| 07/01/2021 |
4
| venBio Global Strategic Fund III, L.P. (10% Owner) has filed a Form 4 on Elevation Oncology, Inc.|
Txns:
| Converted 1,983,167 shares
@ $0
Bought 625,000 shares
@ $16, valued at
$10M
Converted 8,380,034 preferred shares
@ $0 |
|
| 06/24/2021 |
3
| venBio Global Strategic Fund III, L.P. (10% Owner) has filed a Form 3 on Elevation Oncology, Inc. |
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2021 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on IMPEL NEUROPHARMA INC|
Txns:
| Converted 2,309,791 shares
@ $0
Bought 450,000 shares
@ $15, valued at
$6.8M
Converted 5,876,034 options to buy
@ $0
Converted 8,201,930 options to buy
@ $0
Converted 8,845,942 options to buy
@ $0
Converted 13,233,885 options to buy
@ $0
Converted convertible notes
@ $0 |
|
| 04/26/2021 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on IMPEL NEUROPHARMA INC|
Txns:
| Acquired convertible notes
@ $0 |
|
| 04/22/2021 |
3
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 3 on IMPEL NEUROPHARMA INC |
| 09/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/15/2020 |
3
| venBio Global Strategic Fund, L.P. (10% Owner) has filed a Form 3 on Metacrine, Inc. |
| 08/12/2020 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Converted 3,473,374 shares
@ $0
Bought 200,000 shares
@ $15, valued at
$3M
Converted 12,500,000 preferred shares
@ $0
Converted 8,753,350 preferred shares
@ $0
Converted 3,644,624 preferred shares
@ $0 |
|
| 08/06/2020 |
3
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 3 on Checkmate Pharmaceuticals, Inc. |
| 07/21/2020 |
4
| GOODMAN COREY S (10% Owner) has filed a Form 4 on ALX ONCOLOGY HOLDINGS INC|
Txns:
| Converted 3,100,020 shares
@ $0
Bought 850,000 shares
@ $19, valued at
$16.2M
Converted 3,941,949 shares
@ $0
Converted 93,969 shares
@ $0
Converted 52,647 shares
@ $0
Converted 3,100,020 options to buy
@ $0
Converted 2,398,588 options to buy
@ $0
Converted 490,411 options to buy
@ $0
Converted 1,052,950 options to buy
@ $0
Converted 78,175 options to buy
@ $0
Converted 15,794 options to buy
@ $0 |
|
| 07/17/2020 |
4
| GOODMAN COREY S (10% Owner) has filed a Form 4 on ALX ONCOLOGY HOLDINGS INC|
Txns:
| Granted 24,009 options to buy
@ $19, valued at
$456.2k
|
|
| 07/16/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/06/2020 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 108,064 shares
@ $34.4519, valued at
$3.7M
Sold 3,800 shares
@ $33.633, valued at
$127.8k
Sold 4,603 shares
@ $33.8304, valued at
$155.7k
|
|
| 03/06/2020 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 35,650 shares
@ $23.8083, valued at
$848.8k
Sold 8,500 shares
@ $23.5307, valued at
$200k
Sold 1,800 shares
@ $23.7949, valued at
$42.8k
|
|
| 03/03/2020 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 5,100 shares
@ $21.3044, valued at
$108.7k
Sold 10,297 shares
@ $23.061, valued at
$237.5k
Sold 6,401 shares
@ $22.9962, valued at
$147.2k
|
|
| 02/27/2020 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 1,600 shares
@ $23.6725, valued at
$37.9k
Sold 2,523 shares
@ $22.4397, valued at
$56.6k
Sold 1,781 shares
@ $22.54, valued at
$40.1k
|
|
| 02/12/2020 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 7,836 shares
@ $27.0761, valued at
$212.2k
Sold 2,184 shares
@ $27.0458, valued at
$59.1k
Sold 6 shares
@ $27.14, valued at
$162.8 |
|
| 02/10/2020 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 6,102 shares
@ $27.0329, valued at
$165k
|
|
| 02/06/2020 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 53,731 shares
@ $25.6496, valued at
$1.4M
Sold 28,608 shares
@ $25.9909, valued at
$743.5k
|
|
| 01/14/2020 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 494,000 shares
@ $20.23, valued at
$10M
|
|
|
|
|